Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4576
Tyra Biosciences
TYRA
$1.9B
| $27.2K | ﹤0.01% |
3,581
+3,025
| +544% | +$21.4K |
|
|
DBGR
4577
DELISTED
Xtrackers MSCI Germany Hedged Equity ETF
DBGR
| $27.1K | ﹤0.01% |
1,000
| – | – |
|
4578
GoodRx Holdings
GDRX
$1.04B
| $27K | ﹤0.01% |
5,787
+216
| +4% | +$1.06K |
|
4579
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $26.8K | ﹤0.01% |
248
| – | – |
|
|
ATCX
4580
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $26.5K | ﹤0.01% |
5,144
+4,352
| +549% | +$27.1K |
|
|
MPX
4581
DELISTED
Marine Products Corp
MPX
| $26.3K | ﹤0.01% |
2,233
+1,880
| +533% | +$19.8K |
|
4582
Velocity Financial
VEL
$689M
| $26.2K | ﹤0.01% |
2,712
+1,824
| +205% | +$18.3K |
|
|
RVLP
4583
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $26.1K | ﹤0.01% |
23,317
+20,468
| +718% | +$32.6K |
|
4584
Lifetime Brands
LCUT
$191M
| $26.1K | ﹤0.01% |
3,435
+2,893
| +534% | +$22.3K |
|
4585
Playboy Inc
PLBY
$128M
| $25.8K | ﹤0.01% |
9,373
+5,270
| +128% | +$18.9K |
|
4586
FTAI Aviation
FTAI
$21.1B
| $25.7K | ﹤0.01% |
1,499
-14,803
| -91% | -$249K |
|
4587
iShares MSCI France ETF
EWQ
$335M
| $25.3K | ﹤0.01% |
765
| – | – |
|
4588
Traeger
COOK
$178M
| $25.1K | ﹤0.01% |
178
+151
| +559% | +$25.2K |
|
4589
Praxis Precision Medicines
PRAX
$8.58B
| $25.1K | ﹤0.01% |
703
+596
| +557% | +$18.6K |
|
|
CRESY
4590
Cresud
CRESY
$795M
| $25.1K | ﹤0.01% |
3,900
| – | – |
|
4591
Priority Technology Holdings
PRTH
$535M
| $25K | ﹤0.01% |
4,759
+4,000
| +527% | +$20.3K |
|
4592
CleanSpark
CLSK
$3.53B
| $25K | ﹤0.01% |
12,253
+10,318
| +533% | +$26.7K |
|
4593
PUT
ChargePoint
CHPT
$141M
| $24.8K | ﹤0.01% |
+130
| New | +$31.6K |
|
4594
Telecom Argentina
TEO
$6.03B
| $24.5K | ﹤0.01% |
+4,500
| New | +$19.3K |
|
4595
EyePoint Inc
EYPT
$1.03B
| $24.5K | ﹤0.01% |
7,005
+5,899
| +533% | +$26K |
|
4596
SelectQuote
SLQT
$132M
| $24.4K | ﹤0.01% |
36,353
+3,955
| +12% | +$2.59K |
|
4597
Vertex
VERX
$2.09B
| $24.2K | ﹤0.01% |
1,670
+82
| +5% | +$1.31K |
|
4598
Local Bounti
LOCL
$22.8M
| $24.1K | ﹤0.01% |
1,336
+1,196
| +854% | +$37.3K |
|
4599
Solid Biosciences
SLDB
$794M
| $23.9K | ﹤0.01% |
4,437
-1
| -0% | -$7 |
|
4600
iShares Self-Driving EV and Tech ETF
IDRV
$125M
| $23.7K | ﹤0.01% |
700
| – | – |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.